Corient Private Wealth’s Oric Pharmaceuticals ORIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$527K Buy
+39,094
New +$487K ﹤0.01% 2417
2026
Q1
– Sell
-12,512
Closed -$102K – 2951
2025
Q4
$102K Buy
+12,512
New +$144K ﹤0.01% 2545

Other funds holding ORIC

Corient Private Wealth's ORIC Position: Q3 2026 in Review

Corient Private Wealth opened a new position in Oric Pharmaceuticals (ORIC) in Q3 2026: 39,094 shares worth $527K. The stake represents ﹤0.01% of the portfolio and ranks #2417 among its holdings. This is a return to the name: Corient Private Wealth previously reported a position in ORIC as recently as Q4 2025.

Corient Private Wealth first reported a position in ORIC in Q4 2025 and has held it in 2 quarters since. 202 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.

  • Corient Private Wealth held 39,094 shares of Oric Pharmaceuticals worth $527K as of Q3 2026.
  • Oric Pharmaceuticals was a new Corient Private Wealth position in Q3 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of Corient Private Wealth's portfolio in Q3 2026, its #2417 holding.
  • Corient Private Wealth first reported a position in Oric Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 202 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.

Based on Corient Private Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.